China Cancer Vaccines Market Report & Forecast 2021-2027

China Cancer Vaccines Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Cancer Vaccines Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Cancer Vaccines Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Cancer Vaccines Overall Market Size
2.1 China Cancer Vaccines Market Size: 2021 VS 2027
2.2 China Cancer Vaccines Revenue, Prospects & Forecasts: 2016-2027
2.3 China Cancer Vaccines Sales: 2016-2027
3 Company Landscape
3.1 Top Cancer Vaccines Players in China Market
3.2 Top China Cancer Vaccines Companies Ranked by Revenue
3.3 China Cancer Vaccines Revenue by Companies
3.4 China Cancer Vaccines Sales by Companies
3.5 China Cancer Vaccines Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Cancer Vaccines Companies in China Market, by Revenue in 2020
3.7 Manufacturers Cancer Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cancer Vaccines Players in China Market
3.8.1 List of Tier 1 Cancer Vaccines Companies in China
3.8.2 List of Tier 2 and Tier 3 Cancer Vaccines Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Cancer Vaccines Market Size Markets, 2021 & 2027
4.1.2 Preventive Cancer Vaccines
4.1.3 Therapeutic Cancer Vaccines
4.2 By Type - China Cancer Vaccines Revenue & Forecasts
4.2.1 By Type - China Cancer Vaccines Revenue, 2016-2021
4.2.2 By Type - China Cancer Vaccines Revenue, 2022-2027
4.2.3 By Type - China Cancer Vaccines Revenue Market Share, 2016-2027
4.3 By Type - China Cancer Vaccines Sales & Forecasts
4.3.1 By Type - China Cancer Vaccines Sales, 2016-2021
4.3.2 By Type - China Cancer Vaccines Sales, 2022-2027
4.3.3 By Type - China Cancer Vaccines Sales Market Share, 2016-2027
4.4 By Type - China Cancer Vaccines Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Cancer Vaccines Market Size, 2021 & 2027
5.1.2 Cervical Cancer
5.1.3 Prostate Cancer
5.1.4 Others
5.2 By Application - China Cancer Vaccines Revenue & Forecasts
5.2.1 By Application - China Cancer Vaccines Revenue, 2016-2021
5.2.2 By Application - China Cancer Vaccines Revenue, 2022-2027
5.2.3 By Application - China Cancer Vaccines Revenue Market Share, 2016-2027
5.3 By Application - China Cancer Vaccines Sales & Forecasts
5.3.1 By Application - China Cancer Vaccines Sales, 2016-2021
5.3.2 By Application - China Cancer Vaccines Sales, 2022-2027
5.3.3 By Application - China Cancer Vaccines Sales Market Share, 2016-2027
5.4 By Application - China Cancer Vaccines Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Glaxosmithkline
6.1.1 Glaxosmithkline Corporation Information
6.1.2 Glaxosmithkline Overview
6.1.3 Glaxosmithkline Cancer Vaccines Sales and Revenue in China Market (2016-2021)
6.1.4 Glaxosmithkline Cancer Vaccines Product Description
6.1.5 Glaxosmithkline Recent Developments
6.2 Astellas Pharma
6.2.1 Astellas Pharma Corporation Information
6.2.2 Astellas Pharma Overview
6.2.3 Astellas Pharma Cancer Vaccines Sales and Revenue in China Market (2016-2021)
6.2.4 Astellas Pharma Cancer Vaccines Product Description
6.2.5 Astellas Pharma Recent Developments
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Overview
6.3.3 Merck Cancer Vaccines Sales and Revenue in China Market (2016-2021)
6.3.4 Merck Cancer Vaccines Product Description
6.3.5 Merck Recent Developments
6.4 CSL Limited
6.4.1 CSL Limited Corporation Information
6.4.2 CSL Limited Overview
6.4.3 CSL Limited Cancer Vaccines Sales and Revenue in China Market (2016-2021)
6.4.4 CSL Limited Cancer Vaccines Product Description
6.4.5 CSL Limited Recent Developments
6.5 Sanpower Group
6.5.1 Sanpower Group Corporation Information
6.5.2 Sanpower Group Overview
6.5.3 Sanpower Group Cancer Vaccines Sales and Revenue in China Market (2016-2021)
6.5.4 Sanpower Group Cancer Vaccines Product Description
6.5.5 Sanpower Group Recent Developments
6.6 Sanofi Pasteur
6.6.1 Sanofi Pasteur Corporation Information
6.6.2 Sanofi Pasteur Overview
6.6.3 Sanofi Pasteur Cancer Vaccines Sales and Revenue in China Market (2016-2021)
6.6.4 Sanofi Pasteur Cancer Vaccines Product Description
6.6.5 Sanofi Pasteur Recent Developments
6.7 Pfizer
6.7.1 Pfizer Corporation Information
6.7.2 Pfizer Overview
6.7.3 Pfizer Cancer Vaccines Sales and Revenue in China Market (2016-2021)
6.7.4 Pfizer Cancer Vaccines Product Description
6.7.5 Pfizer Recent Developments
6.8 Serum Institute of India
6.8.1 Serum Institute of India Corporation Information
6.8.2 Serum Institute of India Overview
6.8.3 Serum Institute of India Cancer Vaccines Sales and Revenue in China Market (2016-2021)
6.8.4 Serum Institute of India Cancer Vaccines Product Description
6.8.5 Serum Institute of India Recent Developments
7 China Cancer Vaccines Production Capacity, Analysis
7.1 China Cancer Vaccines Production Capacity, 2016-2027
7.2 Cancer Vaccines Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Cancer Vaccines Supply Chain Analysis
9.1 Cancer Vaccines Industry Value Chain
9.2 Cancer Vaccines Upstream Market
9.3 Cancer Vaccines Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Cancer Vaccines Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Cancer Vaccines in China Market
Table 2. Top Cancer Vaccines Players in China Market, Ranking by Revenue (2019)
Table 3. China Cancer Vaccines Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Cancer Vaccines Revenue Share by Companies, 2016-2021
Table 5. China Cancer Vaccines Sales by Companies, (K MT), 2016-2021
Table 6. China Cancer Vaccines Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Cancer Vaccines Price (2016-2021) & (USD/MT)
Table 8. Manufacturers Cancer Vaccines Product Type
Table 9. List of Tier 1 Cancer Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Cancer Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Preventive Cancer Vaccines
Table 12. Major Manufacturers of Therapeutic Cancer Vaccines
Table 13. By Type - China Cancer Vaccines Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Cancer Vaccines Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Cancer Vaccines Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Cancer Vaccines Sales (K MT), 2016-2021
Table 17. By Type - China Cancer Vaccines Sales (K MT), 2022-2027
Table 18. By Application - China Cancer Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Cancer Vaccines Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Cancer Vaccines Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Cancer Vaccines Sales (K MT), 2016-2021
Table 22. By Application - China Cancer Vaccines Sales (K MT), 2022-2027
Table 23. Glaxosmithkline Corporation Information
Table 24. Glaxosmithkline Description and Major Businesses
Table 25. Glaxosmithkline Cancer Vaccines Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 26. Glaxosmithkline Cancer Vaccines Product
Table 27. Glaxosmithkline Recent Developments
Table 28. Astellas Pharma Corporation Information
Table 29. Astellas Pharma Description and Major Businesses
Table 30. Astellas Pharma Cancer Vaccines Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 31. Astellas Pharma Cancer Vaccines Product
Table 32. Astellas Pharma Recent Developments
Table 33. Merck Corporation Information
Table 34. Merck Description and Major Businesses
Table 35. Merck Cancer Vaccines Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 36. Merck Cancer Vaccines Product
Table 37. Merck Recent Developments
Table 38. CSL Limited Corporation Information
Table 39. CSL Limited Description and Major Businesses
Table 40. CSL Limited Cancer Vaccines Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 41. CSL Limited Cancer Vaccines Product
Table 42. CSL Limited Recent Developments
Table 43. Sanpower Group Corporation Information
Table 44. Sanpower Group Description and Major Businesses
Table 45. Sanpower Group Cancer Vaccines Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 46. Sanpower Group Cancer Vaccines Product
Table 47. Sanpower Group Recent Developments
Table 48. Sanofi Pasteur Corporation Information
Table 49. Sanofi Pasteur Description and Major Businesses
Table 50. Sanofi Pasteur Cancer Vaccines Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 51. Sanofi Pasteur Cancer Vaccines Product
Table 52. Sanofi Pasteur Recent Developments
Table 53. Pfizer Corporation Information
Table 54. Pfizer Description and Major Businesses
Table 55. Pfizer Cancer Vaccines Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 56. Pfizer Cancer Vaccines Product
Table 57. Pfizer Recent Developments
Table 58. Serum Institute of India Corporation Information
Table 59. Serum Institute of India Description and Major Businesses
Table 60. Serum Institute of India Cancer Vaccines Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 61. Serum Institute of India Cancer Vaccines Product
Table 62. Serum Institute of India Recent Developments
Table 63. Cancer Vaccines Production Capacity (K MT) of Key Manufacturers in China Market, 2019-2021 (K MT)
Table 64. China Cancer Vaccines Capacity Market Share of Key Manufacturers, 2019-2021
Table 65. Cancer Vaccines Market Opportunities & Trends in China Market
Table 66. Cancer Vaccines Market Drivers in China Market
Table 67. Cancer Vaccines Market Restraints in China Market
Table 68. Cancer Vaccines Raw Materials
Table 69. Cancer Vaccines Raw Materials Suppliers in China Market
Table 70. Typical Cancer Vaccines Downstream
Table 71. Cancer Vaccines Downstream Clients in China Market
Table 72. Cancer Vaccines Distributors and Sales Agents in China Market
List of Figures
Figure 1. Cancer Vaccines Product Picture
Figure 2. Cancer Vaccines Segment by Type
Figure 3. Cancer Vaccines Segment by Application
Figure 4. China Cancer Vaccines Market Overview: 2020
Figure 5. China Cancer Vaccines Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Cancer Vaccines Revenue, 2016-2027 (US$, Mn)
Figure 7. Cancer Vaccines Sales in China Market: 2016-2027 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Cancer Vaccines Revenue in 2020
Figure 9. Preventive Cancer Vaccines Product Picture
Figure 10. Therapeutic Cancer Vaccines Product Picture
Figure 11. By Type - China Cancer Vaccines Sales Market Share, 2016-2027
Figure 12. By Type - China Cancer Vaccines Revenue Market Share, 2016-2027
Figure 13. By Type - China Cancer Vaccines Price (USD/MT), 2016-2027
Figure 14. Cervical Cancer
Figure 15. Prostate Cancer
Figure 16. Others
Figure 17. By Application - China Cancer Vaccines Sales Market Share, 2016-2027
Figure 18. By Application - China Cancer Vaccines Revenue Market Share, 2016-2027
Figure 19. By Application - China Cancer Vaccines Price (USD/MT), 2016-2027
Figure 20. Glaxosmithkline Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Astellas Pharma Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Merck Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. CSL Limited Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Sanpower Group Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Sanofi Pasteur Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Pfizer Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Serum Institute of India Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. China Cancer Vaccines Production Capacity (K MT), 2016-2027
Figure 29. Cancer Vaccines Industry Value Chain
Figure 30. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global BCG Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global BCG Vaccine market size was valued at US$ 365.6 million in 2023. With growing demand in downstream market, the BCG Vaccine is forecast to a readjusted size of US$ 542.8 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global BCG Vaccine market. BCG Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Peptide Cancer Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Peptide Cancer Vaccine market size was valued at US$ 535 million in 2023. With growing demand in downstream market, the Peptide Cancer Vaccine is forecast to a readjusted size of US$ 1978.2 million by 2030 with a CAGR of 20.5% during review period. The research report highlights the growth potential of the global Peptide Cancer Vaccine market. Peptide Cancer Vaccine are expected to show stable growth in the future market. How......

Global Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Vaccine market: According to our latest research, the global Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Cancer Vaccine market was estimated at USD 7198.2 million, and it's anticipated to reach USD 33936.62 million in 2028, with a CAGR of 29.49% during the forecast years. A cancer vaccine is a type of immunotherapy that boost the body's natural defenses by stimulating the immune system to recognize and cur......

Global Lung Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 12-Dec-2023        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Lung Cancer Vaccines market: According to our latest research, the global Lung Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Lung Cancer Vaccines market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Lung Cancer Vaccines,A cancer vaccine for lung cance This report covers a research time span from 2018 to 2028, and ......

Global Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 105

Market Overview of Global Cancer Vaccines market: According to our latest research, the global Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Cancer Vaccines market was estimated at USD 5773.14 million, and it's anticipated to reach USD 15406.41 million in 2028, with a CAGR of 17.77% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Vacci......

Global Dendritic Cell Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 110

Market Overview of Global Dendritic Cell Cancer Vaccine market: According to our latest research, the global Dendritic Cell Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Dendritic Cell Cancer Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Dendritic cells (DC) are one of the major antigen presenting cells found in lymphoid organs. The main fu......

Global BCG Vaccine Market Research Report 2023, Forecast to 2028

Published: 14-Nov-2023        Price: US 2680 Onwards        Pages: 135

BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......

Global BCG Vaccine Professional Survey Report 2023, Forecast to 2028

Published: 14-Nov-2023        Price: US 3280 Onwards        Pages: 105

BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......

Infectious Vaccine Collaboration and Licensing Deals 2016-2023

Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 300

Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the infectious vaccine deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of infectious vaccine deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter infectious vaccine deals. These deals tend to be multicomponent, starting with......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs